Лимфома из клеток мантийной зоны: клинические формы, морфологические варианты, диагностика и лечение
Диссертация
Лимфома из клеток мантийной зоны (JIKM3) — обычно генерализованная лимфатическая опухоль, характеризующаяся агрессивным клиническим течением, которое проявляется в малой эффективности стандартной химиотерапии зрелоклеточных лимфом, высокой частоте бластной трансформации, короткой общей и безрецидивной выживаемости больных. В большинстве случаев опухолевая ткань представлена морфологически зрелыми… Читать ещё >
Список литературы
- Воробьев А. И., Бриллиант М. Д. Лимфоцитома селезенки и классификация лимфоцитом. Тер Арх 1982−8:8−14
- Воробьев А. И., Кременецкая А. М., Харазишвили Д. В. Опухоли лимфатической системы. Гематол трансфузиол 2000−3:3−14
- Воробьев А.И., Бриллиант М. Д. Дифференцированная терапия хронического лимфолейкоза. Тер Арх 1983−8:7−14
- Воробьев А.И., Бриллиант М. Д. Патогенез и терапия лейкозов. Медицина, 1976, с. 42−52.
- Воробьев А.И., Кременецкая A.M., Лорие Ю. Ю., и др. «Старые» и «новые» опухоли лимфатической системы. Тер Арх 2000−7:9−13
- Глузман Д.Ф., Сидоренко С. П., Надгорная Н. А., и др. Цитохимия и иммуноцитология злокачественных лимфопролиферативных заболеваний. Киев, Наук. Думка, 1982, стр.240
- Двойрин В.В., Клименков А.А. Методика контролируемых клинических испытаний, Москва «Медицина», 1985
- Кассирский И.А., Алексеев Г. А. Клиническая гематология. Москва, Медицина, 1970, стр. 412−420.
- Кременецкая A.M., Воробьев И. А., Сидорова Ю. В., и др. Морфология лимфоцитов. Тер Архив, 1998−7:37−39
- Самойлова Р.С., Даровский Б. М., Лукина Е. А., и др. Диагностика реактивных лимфаденопатий и стадии лейкемизации лимфосарком с использованием наиболее простых методов иммунологического фенотипирования. Тер. Арх. 1986−9:72−77
- Синицина Т.В., Андреева Н. Е., Абелев Г. И. Секреция моноклональных иммуноглобулинов при хронических лимфопролиферативных заболеваниях. Тер Архив 1988−60(5):50−3
- Adkins D., Brown R., Goodnough L.T., et al. Treatment of resistant mantle cell lymphoma with allogeneic bone marrow transplantation. Bone Marrow Transplant 1998−21:97−99
- Agratoff L.H., Connors J.M., Klasa R.J., et al. Mantle cell lymphoma: a clinicopathologic study of 80 cases. Blood, 1997−89:2067−2078
- Andersen N.S., Jensen M.K., de Nully Brown P., et al. A Danish population-based analysis of 105 mantle cell lymphoma patients: incidences, clinical features, response, survival and prognostic factors. Eur J Cancer 2002−38:401−408
- Anon. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. The Non-Hodgkin's Lymphoma Classification Project. Blood 1997−89:3909−3918
- Anon. The World Health Organisation classification of malignant lymphomas in Japan: Incidence of recently recognized entities. Pathol Int 2000−50:696−702
- Arcinas M., Heckman C.A., Mehew J.W., et al. Molecular Mechanisms of Transcriptional Control of bcl-2 and с-myc in Follicular and Transformed Lymphoma. Cancer Res 2001 -61:5202−5206
- Au W.Y., Horsman D.E., Viswanatha D.S. 8q24 translocations in blastic transformation of mantle cell lymphoma. Haematologica 2000−85:1225−1226
- Bagui Т.К., Mohapatra S., Haura E., et al. p27Kipl and p21Cipl Are Not Required for the Formation of Active D Cyclin-cdk4 Complexes. Mol Cell Biol, 2003−23:7285−7290
- Banks P.M., Chan J., Cleary M.L., et al: Mantle cell lymphoma. A proposal for unification of morphologic, immunologic, and molecular data. Am J Surg Pathol 1992−16:637−640
- Barekman C.L., Aguilera N.S.I., Abbondanzo S.L. Low-Grade B-Cell Lymphoma With Coexpression of Both CD5 and CD 10. Arch Pathol Lab Med 2001−125:951−953
- Barista I., Cabanillas F., Romaguera J.E., et al. Is there an increased rate of additional malignancies in patients with mantle cell lymphoma? Ann Oncol 2002−13:318−322
- Barista I., Romaguera J.E., Cabanillas F. Mantle-cell lymphoma. Lancet Oncol 2001−3:141−48−136
- Barry T.S., Jaffe E.S., Kingma D.W., et al. (2002) CD5+ Follicular Lymphoma. Am J Clin Pathol- 118:589−598-
- Becker S., Babisch J., Venbrocks R., et al. Primary non-Hodgkin lymphoma of the spine. Arch Orthop Trauma Surg 1998- 117:399-^01
- Belaud-Rotureau M-A., Parrens M., Dubus P., et al. A Comparative Analysis of FISH, RT-PCR, PCR, and Immunohistochemistry for the Diagnosis of Mantle Cell Lymphomas Mod Pathol 2002−15:517−525
- Bell N.D., King J.A.C., Kusyk C., et al. CD5 negative mantle cell lymphoma with splenomegaly and bone marrow involvement. South Med J 1998−91:584−587
- Bentz M., Plesch A., Bullinger L., et al. t (ll-14)-Positive Mantle Cell Lymphomas Exhibit Complex Karyotypes and Share Similarities With B-Cell Chronic Lymphocytic Leukemia. Genes Chrom Cancer 2000−27:285−294
- Berard C.W., Dorfman R.F. Histopathology of malignant lymphomas. Clin Hematol 1974−3:39
- Bertoni F. Molecular basis of mantle cell lymphoma. Br J Haematol 2004−124:130−140
- Bertoni F., Roggero E., Luscieti P., et al. Clonality assessment in blood of patients with with mantle cell lymphoma. Leuk & Lymph 1999−32:375−379
- Bhatia S., Paulino A.C., Buatti J.M. et al. Curative radiotherapy for primary orbital lymphoma. Int J Radiation Oncology Biol Phys 2002−54:818−823
- Bigoni R., Cuneo A., Milani R., et al. Secondary chromosome changes in mantle cell lymphoma: cytogenetic and fluorescence in situ hybridization studies. Leuk Lymphoma 2001−40:581−590
- Blackshaw AJ. Non-Hodgkin's lymphoma of the gut. In: Wright R, editor. Recent advances in gastrointestinal pathology. East-bournes, East Sussex (England): WB Sanders- 1980, p. 213−40
- Bogner C., Ringshausen I., Schneller F., et al. Inhibition of the proteasome induces cell cycle arrest and apoptosis in mantle cell lymphoma cells. Br J Haematol 2003−122:260−268
- Bosch F., Jares P., Campo E., et al. PRADl/cyclin Dl gene overexpression in chronic lymphoproliferative disoders: a highly specific marker of mantle cell lymphoma. Blood 1994−84:2726
- Bosch F., Lopez-Guillermo A., Campo E., et al. Mantle Cell Lymphoma Presenting Features, Response to Therapy, and Prognostic Factors. Cancer 1998−82:567−75
- Brito-Babapulle V., Ellis J., Matutes E. et al. Chromosome translocation11−14)(ql3:q32) in chronic lymphoid disorders. Genes Chromosomes Cancer 1992−5:158−165
- Caligaris-Cappio F., Riva M., Tesio L., et al. Human normal CD5+ В lymphocytes can be induced to differentiate to CD5- В lymphocytes with germinal center features. Blood 1989−73:1259
- Camacho F.I., Algara P., Rodriguez A., et al. Molecular heterogeneity in MCL, defined by the use of specific VH genes and the frequency of somatic mutations. Blood 2003−101:4042−4046
- Chan J.A., Bu X., Lai K.K., et al. Mantle Cell Lymphoma, «Blastoid» Variant (WHO Classification), Producing Distinctive Morphologic Patterns. Pathol Case Rev 2002−7:88−96
- Chiarle R., Budel L.M., Skolnik J., et al. Increased proteasome degradation of cyclin-dependent kinase inhibitor p27 is associated with a decreased overall survival in mantle cell lymphoma. Blood 2000−95:619−626
- Chung H-H., Kim Y.H., Kim J.H., et al. Imaging findings of mantle cell lymphoma involving gastrointestinal tract. Yonsei Med J 2003−44:49−57
- Coiffier B. What treatment for mantle cell lymphoma patients in 1998? J Clin Oncol 1998−16:3−5
- Coiffier В., Hiddemann W., Stein H. Mantle cell lymphoma: a therapeutic dilemma. Ann Oncol 1995−6:208−212
- Connors J.M., Kouroukis C., Belch A., et al. Flavopiridol for Mantle Cell Lymphoma: Moderate Activity and Frequent Disease Stabilization. ASH 2001, Orlando, Florida, Dec 7−11, ab#3355
- Cordell J.L., Falini В., Erber W.N., and al. Immunoenzymatic labelling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J Histochem Cytochem 1984−32:219−229
- Cornes J.S., Multiple lymphomatous polyposis of the gastrointestinal tract. Cancer 1961−14:249−257
- Cuneo A., Bigoni R., Rigolin G.M., et al. Cytogenetic profile of lymphoma of follicle mantle lineage: correlation with clinicobiologic features. Blood 1999−93:1372−1380
- Dean A., Rogers Т.Е., Diehl J., et al. Multifocal intracranial involvement with mantle cell lymphoma. J Clin Oncol 2002−20:340−342
- Decaudin D. Mantle Cell Lymphoma: A Biological and Therapeutic Paradigm. Leuk Lymphoma 2002−43:773−781
- Delmer A., Ajchenbaum-Cymbalista F., Tang R., et al. Over-expression of cyclin D1 in chronic B-ceII malignancies with abnormality of chromosome 1 lql3. Br J Haematol 1995−89:798−804
- Doner H., Stilgenbauer S., Benner A., et al. Genomic aberration and survival in chronic lymphocytic leukemia. N Eng J Med 2000−343:1910−1916
- Dubus P., Young P., Beylot-Barry M., et al. Value of Interphase FISH for the Diagnosis of t (l I-14)(ql3-q32) on Skin Lesions of Mantle Cell Lymphoma. Am J Clin Pathol 2002- 118:832−841
- Duggan M.J., Weisenburger D.D., Ye Y.L., et al. Mantle zone lymphoma. A clinicopathologic study of 22 cases. Cancer 1990−66:522
- Edward A., Wilson E.A., Jobanputra S., et al. Response to thalidomide in chemotherapy-resistant mantle cell lymphoma: a case report. Br J Haematol 2002−119:128−130
- Eeles R.A., O’Brien P., Horwich A., et al. Non- Hodgkin’s lymphoma presenting with extradural spinal cord compression: functional outcome and survival. Br J Cancer 1991−63:126−129
- Ek S., Hogerkorp K.M., Dictor M., et al. Mantle Cell Lymphomas Express a Distinct Genetic Signature Affecting Lymphocyte Trafficking and Growth Regulation as Compared with Subpopulations of Normal Human В Cells. Cancer Res 2002−62:4398−4405
- Ekholm S.V., Reed S.I. Regulation of G1 cyclin-dependent kinases in the mammalian cell cycle. Curr Opin Cell Biol 2000−12:676−684
- Esmaeli В., Ahmadi M.A., Manning J., et al. Clinical presentation and treatment of secondary orbital lymphoma. Ophtal Plast Reconstr Surg 2002−18:247−253
- Fadare O., Shukla P. Another case of mantle cell lymphoma presenting as breast masses. J Clin Pathol 2002−55:640
- Fan H., Gulley M.L., Gascoyne R.D., et al. Molecular methods for detecting t (11- 14) translocations in mantle-cell lymphomas. Diagnostic Molecular Pathology 1998−7:209−214
- Fang N.Y., Greiner T.C., Weisenburger D.D., et al. Oligonucleotide microarrays demonstrate the highest frequency of ATM mutations in the mantle cell subtype of lymphoma. PNAS 2003−100:5372−5377
- Figgis P.A., Rainer S.P., Ma D., et al. Endobronchial mantle cell lymphoma. Intern Med J 2003−33:261
- Finsterer J., Lubec D., Jellinger K., et al. Recovery from coma caused by primary CNS mantle cell lymphoma presenting as encephalitis. Neurology 1996−46:824−826
- Fischer M., Klein U., Kiippers R. Molecular Single-cell Analysis Reveals that CD5-positive Peripheral Blood В Cells in Healthy Humans are Characterized by Rearranged Yk Genes Lacking Somatic Mutation. J Clin Invest 1997−100:1667— 1676
- Fisher R.I. Mantle Cell Lymphoma: Prognostic Factors and Treatment Results. Hematology 1999:325−329
- Fonseca R., Blood E.A., Oken M.M. et al. Myeloma and the t (l 1−14) (ql3-q32) — evidence for a biologically defined unique subset of patients. Blood 2002- 99: 3735−3741
- Freedman A.S., Neuberg D., Gribben J.G. High-dose chemoradiotherapy and anti-B-cell monoclonal antibody-purged autologous bone marrow transplantation in mantle-cell lymphoma: no evidence for long-term remission. J Clin Oncol 1998−16:13−18
- Gaidano G., Hauptschein R.S., Parsa N.Z. et al. Deletions involving two distinct regions of 6q in B-cell non-Hodgkin's lymphoma. Blood 1992−80: 1781−1787
- Gerard-Marchant R., Hamlin I., Lennert K., et al. Classification of non-Hodgkin's lymphomas. Lancet 1974−2:406−408
- Ghielmini M., Schmitz S.F., Burki K., et al. The effect of Rituximab on patients with follicular and mantle-cell lymphoma. Swiss Group for Clinical Cancer Research (SAKK). Ann Oncol 2000−11:123−126
- Gianni A.M., Magni M., Martelli M., et al. Long-term remission in mantle cell lymphoma following high-dose sequential chemotherapy and in vivo rituximab-purged stem cell autografting (R-HDS regimen). Blood 2003−102:749−755
- Gopal A.K., Rajendran J.G., Petersdorf S.H., et al. High-dose chemo-radioimmunotherapy with autologous stem cell support for relapsed mantle cell lymphoma. Blood 2002−99:3158−3162
- Goy A., East K., Mesina O., et al. Report of a phase II study of proteasome inhibitor Bortezomib in patients with relapsed or refractory indolent and aggressive B-cell lymphomas. Hematol J 2003−4Suppl 2.: 129
- Gressin R., Legouffe E., Leroux D., et al. Treatment of mantle-cell lymphomas with the VAD +/- chlorambucil regimen with or without subsequent high-dose therapy and peripheral blood stem-cell transplantation. Ann Oncol 1997−8-Suppl 1:103−106
- Gronbaek K., Nedergaard Т., Andersen M.K., et al. Concurrent disruption of cell cycle associated genes in mantle cell lymphoma: a genotypic and phenotypic study of cyclin Dl, pi 6, pi5, p53 and pRb. Leukemia, 1998−12:1266−1271
- Hahn J.S., Suh C.O., Lee S.Y., et al. Primary lymphoma of the eye. Yonsei Med J 1998−39:196−201
- Hamburg A., Brynes R.K., Reese C., et al. Human cord blood lymphocytes. Ultrastructural and immunologic surface marker characteristics- a comparison with B- and T-cell lymphomas. Lab Invest 1976−34:207
- Harbour J.W., Dean D.C. Rb function in cell-cycle regulation and Apoptosis. Nature Cell Biol 2000−2:E65-E67
- Harnden D.G., Klinger H.P. An International System for Human Cytogenetic Nomenclature. N. Y: ISCN, 1985, p 1−117
- Harris N.L., Bahn A.K. Mantle-zone lymphoma: a pattern, produced by lymphomas of more than one cell type. Am J Surg Pathol 1985−9:872
- Harris N.L., Jaffe E.S., Stein H. et al: A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood 1994−84:1361−1392
- Hernandez L., Fest Т., Cazorla M., et al. p53 Gene Mutations and Protein Overexpression Are Associated With Aggressive Variants of Mantle Cell Lymphomas. Blood 1996−87:3351−3359
- Hiddemann W., Dreyling M., Unterhalt M. Rituximab Plus Chemotherapy in Follicular and Mantle Cell Lymphomas. Sem Oncol 2003−30:16−20
- Flinds P.W., Daudy S.F., Eaton E.N., et al. Function of a human cyclin gene as an oncogene. Proc Natl Acad Sci USA 1994−91:709
- Hoffman D.G., Tucker S.J., Emmanoulides C. CD8-positive mantle cell lymphoma: a report of two cases. Am J Clin Pathol 1998−109:689−694
- Hoffman P.M., McKelvie P., Hall A.J., et al. Intraocular lymphoma: a series of 14 patients with clinicopathological features and treatment outcomes. Eye 2003−17:513−521
- Hon C., Au W.Y., Ma E.S.K., et al. Isolated orbit relapse after allogenic bone marrow transplantation for malignant lymphoma. J Clin Oncol 2002- 20:43 944 395
- Horhing S.J. Diffuse small-cell lymphomas. In Magrath I. Editor. Non-Hodgkins lymphomas, Arnold, 1997
- Jaffe E.S., Harris N.L., Stein H., Vardiman J.W. (eds.) World Health
- Kaleem Z., Wakoff A.R., Smith R.S. et al. Blastic transfrmation of mantle cell lymphoma. Arch Pathol Lab Med 1996−120−577−580
- Kanehira K., Braylan R.C., Lauwers G.Y. Early Phase of Intestinal Mantle Cell Lymphoma: A Report of Two Cases Associated with Advanced Colonic Adenocarcinoma. Mod Pathol 2001−14:811−817
- Ю9.Кар1ап E. L, Meier P. Nonparametric estimation from incomplete observations. J
- K00 C.H., Rappaport H., Sheibani K., et al. Imprint cytology of non-Hodgkin's lymphomas based on a study of 212 immunologically characterized cases: correlation of touch imprints with tissue sections. Human Pathol 1989−20-Suppl.l:l-140
- Kouroukis C.T., Belch A., Crump M., et al. Flavopiridol in untreated or reliapsed mantle-cell lymphoma: results of a phase II study of the National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol 2003−21:1740−1745
- Kroger N., Hoffknecht M., Dreger P. Long-term disease-free survival of patients with advanced mantle-cell lymphoma following high-dose chemotherapy. Bone Marrow Transplant 1998−21:55−57
- Kroger N., Hoffknecht M., Kruger W., et al. Allogeneic bone marrow transplantation for refractory mantle cell lymphoma. Ann Hematol 2000−79:578−580
- Larramendy M.L., Siilonen S.M., Zhu Y. et al. Optimized mitogen stimulation induces proliferation of neoplastic B-cell in chronic lymphocytic leukemia: significance for cytogenetic analysis. Cytogenet Cell Genet 1998−82:215−221
- Laszlo Т., Nagy M., Kelenyi G., et al. Immunoglobulin VH gene mutational analysis suggests that blastic variant of mantle cell lymphoma derives from different stages of B-cell maturation. Leulc Res 2000−24:27−31
- Lazzarino M., Morra E., Rosso R., et al. Clinicopathologic and immunologic characteristics of non-Hodgkin's lymphoma presenting in the orbit. Cancer 1985−55:1907−12
- Lebacq E. Gastric localizations of chronic lymphoid leukemia. Sem Hop 1969−45:1170−1172
- Leitch H.A., Gascoyne R.D., Chhanabhai M., et al. Limited stage mantle cell lymphoma: Clinical outcome in patients from British Columbia. Blood2001 -98:1443
- Leitch H.A., Gascoyne R.D., Chhanabhai M., et al. Limited-stage mantle-cell lymphoma. Ann Oncol 2003−14:1555−1561
- Lennert K., Stein H., Kaiserling E. Cytological and functional criteria for the classification of malignant lymphoma. Br J Cancer 1975−31:29−43
- Lenz G., Dreyling M., Hiddemann W. Mantle cell lymphoma: established therapeutic options and future directions. Ann Hematol 2004−83:71−77
- Leoncini L., Lazzi S, Bellan C., et al. Cell kinetics and cell cycle regulation in lymphomas. J Clin Pathol 2002−55:648−655
- Lin T.S., Howard O.M., Neuberg D.S., et al. Seventy-two hour continuous infusion flavopiridol in relapsed and refractory mantle cell lymphoma. Leuk Lymphoma 2002−43:793−797
- Liu Z., Dong H.Y., Gorczyca W., et al. CD5- Mantle Cell Lymphoma. Am J Clin Pathol 2002- 118:216−224
- Louie D.C., Offit K., Jaslow R., et al. p53 Overexpression as a Marker of Poor Prognosis in Mantle Cell Lymphomas With t (ll- 14)(ql3- q32). Blood 1995−86:2892−2899
- Lyons M.K., O’Neil B.P., Marsh W.R., et al. Primary spinal epidural non I-Iodgkin's lymphoma: report of eight patients and review of the literature. Neurosurgery 1992−30:675−680
- Ma Y., Cress W.D., Haura E.B. Flavopiridol-induced Apoptosis Is Mediated through Up-Regulation of E2F1 and Repression of Mcl-1. Mol Cancer Ther 2003−2:73−81
- Maja Barnard M., Perez-Ordonez В., Rowed D.W., et al. Primary Spinal Epidural Mantle Cell Lymphoma: Case Report Neurosurgery 2000−47:1239−1242
- Majlis A., Pugh W.C., Rodrigues M.A. et al. Mantle cell lymphoma: Corellation of clinical outcome and biologic features with three histilogic variants. J Clin Oncol 1997−15:1664−1671
- MO.Martinez C., Carreras E., Rovira M., et al. Patients with mantle-cell lymphoma relapsing after autologous stem cell transplantation may be rescued by allogeneic transplantation. Bone Marrow Transplant 2000−26: 677−679
- Mi.McDonald A.C., Nicoll J.A.R., Rampling R.P. Non-Hodgkin's lymphoma presenting with spinal cord compression- a clinicopathological review of 25 cases. Eur J Cancer 2000−36:207−213
- McLaughlin P., Grillo-Lypez A.J., Link B.K. Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program. J Clin Oncol 1998−16:2825−2833
- Mertens D., Wolf S., Bullinger L., et al. BCMSUN, a candidate gene for B-cell chronic lymphocytic leukemia and mantle cell lymphoma, has an independently expressed homolog on Ip22-p31, BCMSUNAike. Int J Cancer 2000−88:692−697
- Meusers P., Engelhard M., Bartels H., et al. Multicentre randomized therapeutic trial for advanced centrocytic lymphoma: anthracycline does not improve the prognosis. Hematol Oncol 1989−7:365−380
- Monni O., Oinonen R., Elonen E. et al. Gain of 3q and deletion of 1 lq22 are frequent aberrations in mantle cell lymphoma. Genes Chrom Cancer 1998−21:298−302
- Montserrat E., Bosch F., Lopez-Guillermo A., et al. CNS involvement in mantle-cell lymphoma. J Clin Oncol 1996−14:941−944
- Nakamura S., Matsumoto Т., Iida M., et al. Primary Gastrointestinal Lymphoma in Japan. A Clinieopathologie Analysis of 455 Patients with Special Reference to its Time Trends. Cancer 2003−97:2462−2473
- Namba K., Jaffe E.F., Braylan J., et al. Alkaline positive malignant lymphoma. A subtype of B-cell lymphoma. Am J Clin Pathol 1977−68:535
- Pinyol M., Cobo F., Bea S., et al. pl6(INK4a) gene inactivation by deletions, mutations, and hypermethylation is associated with transformed and aggressive variants of non-Hodgkin's lymphomas. Blood, 1998- 91:2977−2984
- Pittaluga S., Wlodarska I., Stul M.S., et al. Mantle cell lymphoma: A clinicopathologic study of 55 cases. Histopathol 1995−26:17−21
- Poulose K.P., Krishna K.V. A case of acute lymphatic leukaemia with skeletal manifestations. Indian Pract 1966−19:819−822
- Press O.W., Grogan T.M., Fisher T.I. Evaluation and management of mantle cell lymphoma. Adv Leuk Lymph 1996−6:3
- Pritsch O., Maloum K., Magnac C., et al. What do chronic В cell malignances teach us about В cell subsets? Chem Immunol 1997−67:85−101
- Quintanilla-Martinez L., Davies-Hill Т., Fend F., et al. Sequestration of p27Kipl protein by cyclin D1 in typical and blastic variants of mantle cell lymphoma (MCL): implications for pathogenesis. Blood 2003−101:3181−3187
- Radaszkiewicz Т., Hansmann M.L. Primary high-grade malignant lymphomas of bone. Virch Arch 1998−413:269−274
- Rai K.R. Cladribine for the treatment of hairy cell leukemia and chronic lymphocytic leukemia. Semin Oncol 1998−25:19−22
- Rathmell A.J., Gospodarowicz M.K., Sutcliffe S.B. Localised lymphoma of bone: prognostic factors and treatment recommendations. Br J Cancer 1992−66:603−606
- Remes-Troche J.M., De-Anda J., Ochoa V., et al. A Rare Case of Multiple Lymphomatous Polyposis With Widespread Involvement of the Gastrointestinal Tract Arch Pathol Lab Med 2003−127:1028−1030
- Romaguera J.E., Medeiros L. J., Hagemeister F.B., et al. Frequency of Gastrointestinal Involvement and Its Clinical Significance in Mantle Cell Lymphoma. Cancer 2003−97:586−91
- Rummel M.J., Chow K.U., Karakas Т., Reduced-dose cladribine (2-CdA) plus mitoxantrone is effective in the treatment of mantle-cell and low-grade non-Hodgkin's lymphoma. Eur J Cancer 2002−38:1739−1746
- Sen F., Medeiros L.J., Lu D., et al. Mantle Cell Lymphoma Involving Skin. Am
- Takamura H., Terashima K., Yamashita H. Diagnosis and Treatment of Orbital Malignant Lymphoma: A 14-Year Review at Yamagata University Jpn J Ophthalmol 2001 -45:305- 312
- Teodorovic I., Pittaluga S., Kluinnelemans J.C. Efficacy of four different regimens in 64 mantle cell lymphoma cases. Clinicopathologic comparison with 498 other No-Hodgkin's lymphoma suptypes. J Clin Oncol 1995−6:2819−2826
- Thorner A.R., Travis A.C., Hecht J.L., et al. Mantle cell lymphoma of soft tissue. J Clin Oncol 2001−19:3291−3293
- Tilly H., Rossi A., Stamatoullas A. et al. Prognostic value of chromosomal abnormalities in follicular lymphoma. Blood 1994−84:1043−1049
- Tirier C., Zhang Y., Plendl H. et al. Simultaneous presence of t (11- 14) and a variant Burkitt’s translocation in the terminal phase of a mantle cell lymphoma. Leukemia 1996−10:346−350
- Tort F., Camacho E., Bosch F., et al. Familial lymphoid neoplasms in patients with mantle cell lymphoma. Haematologica 2004−89:314−319
- Toussaint D., Massager N., Mathy L. Primary malignant lymphoma of the spine: clinical aspects and therapeutic advances. Acta Orthop Belg 1999−65: 23−32
- Tsujimoto Y., Louie E., Bashir M.M., et al. The reciprocal partners of both the t (14:18) and the t (l 1:14) translocations involved in B-cell neoplasms are rearranged by the same mechanism. Oncogene 1988−2:347−351
- TsujimotoY., Yunis J.J., Onorato-Showe L., et al. Molecular cloning of chromosomal breakpoints of B-cell lymphomas and leukaemias with t (l 1- 14) chromosome translocation. Science 1984−224:1403−1406
- Unterhalt M., Hermann R., Koch P. Long-term Interferon-a maintenence prolongs remission duration in advanced low-grade lymphomas and is related to the efficacy of initial cytoreductive chemotherapy. ASH 1996, WB Saunders, Orlando, FL, Abstr#2683
- Vadlamudi G., Lionetti K.A., Greenberg S., et al. Leukemic phase of mantle cell kymphoma. Two case reports and review of the literature. Arch Pathol Lab Med 1996−120:35−40
- Valdez R., Kroft S.H., Ross. C.W., et al. Cerebrospinal Fluid Involvement in Mantle Cell Lymphoma Mod Pathol 2002−15:1073−1079
- Vandenberghe E., De Wolf-Peeters., Hudson G.V., et al. The clinical outcome of 65 cases of mantle cell lymphoma initially treated with non-intensive therapy by the National British Lymphoma Investigation Group. Br J Hematol 1997−99:842−847
- Vaughan J.J., Winter R.B., Lonstein J.E., et al. Non-Hodgkin lymphoma of the spine. J Bone Joint Surg Am 1998−80:104−110
- Viana H.L., Henrique R.M., Ferreira E.S., et al. Endoscopic Ultrasonography in Multiple Lymphomatous Polyposis. J Clin Gastroenterol 2002−34:150−154
- Vignote M.L., Chicano M., Rodmguez F.J., et al. Multiple lymphomatous polyposis of the GI tract: report of a case and review. Gastroint Endosc 2002−56:579−582
- Walsh S.H., Thorselius M., Johnson A., et al. Mutated Vh genes and preferential VH3−21 use define new subsets of mantle cell lymphoma. Blood 2003−101:4047−4054
- Weisenburger D.D., Armitage J.O. Mantle Cell Lympho’ma-An Entity Comes of Age. Blood 1996−87:4483−4494
- Weisenburger D.D., Kim H., Rappaport H. Mantle-zone lymphoma: a follicular variant of intermediate lymphocytic lymphoma. Cancer 1982−49: 1429−1438
- Weisenburger D.D., Nathwani B.N., Diamond L.W. Malignant lymphoma, intermediate lymphocytic type: A clinicopathologic study of 42 cases. Cancer 1981 -48:1415
- Weisenburger D.D., Sanger W.G., Armitage J.O., et al. Intermediate lymphocytic lymphoma: Immunophenotypic and cytogenetic findings. Blood 1987−69:1617
- Weisenburger D.D., Vose J.M., Greiner T.C., et al. Mantle Cell Lymphoma. A Clinicopathologic Study of 68 Cases From the Nebraska Lymphoma Study Group. Am J Hematol 2000−64:190−196
- Welzel N., Le Т., Marculescu R., et al. Templated nucleotide addition and immunoglobulin JH-gene utilization in t (l 1- 14) junctions: implications for the mechanism of translocation and the origin of mantle cell lymphoma. Cancer Res 2001−61:1629−1636
- Westfall S.Z.A., Matthew D,. Pietenpol J.A. Cell-cycle dysregulation and anticancer therapy. Tr Pharmacol Science 2003−24:139−145
- Williams M.E., Swerdlow S.H., Rosenberg S., et al. Chromosome 11 translocation breakpoints at the PRADl/cyclin D1 gene locus in centrocytic lymphoma. Leukemia 1993−7:241−245
- Windrum P., Moms T.C.M., Catherwood M.A., et al. Mantle cell lymphoma presenting as a breast mass. J Clin Pathol 2001−54:883−886
- Wlodarska I., Pittaluga S., Hagemeijer A. et al. Secondary chromosome changes in mantle cell lymphoma. Haematologica 1999- 84:594−599
- Wohlschaeger C.H., Lannge K., Mmerz H., et al. Aberrant Immunophenotypes of Mantle Cell Lymphomas. Leuk Lymphoma 2003−44:269−273
- Yatabe Y., Suzuki R., Matsuno Y., et al. Morphological spectrum of cyclin Dl-positive mantle cell lymphoma: Study of 168 cases. Pathol Int 2001 -51:747−761
- Zhu Y., Monni O., Francilla K. et al. Deletions at 1 lq23 in different lymphoma subtypes. Haematologica 2000−85:908−912
- Zucca E., Fontana S., Roggero E., et al. Treatment and prognosis of centrocytic (mantle cell) lymphoma: a retrospective analysis of twenty-six patients treated in one institution. Leuk Lymphoma 1994−13:105−10
- Zucca E., Roggero E., Pinotti G., et al. Patterns of survival in mantle cell lymphoma. Ann Oncol 1995−6:257−262
- Zucca E., Stein H., Coiffer B. European lymphoma task force (TLTF): report of the workshop on mantle cell lymphoma (MCL). Ann Oncol 1994−5:507−511
- Zukerberg L.R., Benedict W.F., Arnold A., et al. Expression of the Retinoblastoma Protein in Low-Grade B-Cell Lymphoma: Relationship to Cyclin Dl. Blood 1996−88:268−2761. Благодарности.
- Автор выражает глубокую благодарность своим наставникам и соавторам
- A.В.Гржимоловскому, И. В. Ефимову, В. С. Галузяку, О. Ю. Поповой, Э. Э. Мирзоян, Е. С. Вишневской, Л. Н. Готману, Г. А. Франку, Т. И. Булычевой,
- B.М.Сотникову, М. А. Цейтлиной, Н. И. Скидан, С. А. Марьиной, Е. М. Грецову, И. А. Воробьеву, М. А. Волковой, Д. Ш. Османову.